300937 药易购
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.9941.9207.1375.2930.991
总资产报酬率 ROA (%)-0.4670.9613.6313.0240.632
投入资产回报率 ROIC (%)-0.6031.1604.3363.6090.764

边际利润分析
销售毛利率 (%)11.0398.9098.2977.9475.463
营业利润率 (%)0.1240.3741.5481.1890.272
息税前利润/营业总收入 (%)0.3340.5951.7351.3150.304
净利润/营业总收入 (%)-0.2530.3521.2810.9100.198

收益指标分析
经营活动净收益/利润总额(%)733.332201.638122.624138.56331.309
价值变动净收益/利润总额(%)26.145-10.6832.204-9.55992.533
营业外收支净额/利润总额(%)-12.2274.6441.837-5.089-14.004

偿债能力分析
流动比率 (X)1.5111.6541.7181.6792.200
速动比率 (X)1.0201.0371.0181.0850.962
资产负债率 (%)56.01650.44049.25948.48233.623
带息债务/全部投入资本 (%)37.43137.59237.49937.44620.300
股东权益/带息债务 (%)162.594160.741161.034163.250382.161
股东权益/负债合计 (%)79.57198.120102.791105.482193.798
利息保障倍数 (X)1.4952.93210.9947.1474.686

营运能力分析
应收账款周转天数 (天)25.75912.6777.8194.3932.880
存货周转天数 (天)47.66548.62044.66045.07745.129